Abbie Celniker joined Third Rock Ventures as Partner in 2016. Dr. Celniker brings more than 20 years of proven expertise in leading protein therapeutic discovery and development companies and programs to Eleven Biotherapeutics.. Prior to joining Eleven, Abbie was CEO of Taligen Therapeutics, a biotechnology company focused on complement system. . . . .
Transparentprofile is a community based platform that benchmarks leaders. Users search for positive and negatives news and publish them here together with some basic information's like birthday, height, salary and much more.